[144] Wesco International Inc. SEC Filing

Rhea-AI Filing Summary

Wesco International (WCC) filed a Form 144 reporting a proposed sale of 1,500 shares of common stock through UBS Financial Services on the NYSE, with an aggregate market value of $339,816 and an approximate sale date of 08/26/2025. The shares were acquired as restricted stock units (RSUs): 76 shares issued 02/13/2021 and 1,424 shares issued 02/17/2023. The filer reports no securities sold in the past three months and affirms no undisclosed material adverse information.

Positive

• Clear compliance with Rule 144 reporting requirements, including broker, share count, and acquisition details
• Source of shares disclosed as RSUs with acquisition dates (02/13/2021 and 02/17/2023), aiding transparency
• No sales by the filer in the past three months, as explicitly reported

Negative

• Insider sale planned of 1,500 shares valued at $339,816, which may be viewed negatively by some investors despite being disclosed

Insights

Securities Analyst

TL;DR: Routine insider sale notice: 1,500 shares via UBS, sourced from RSUs, no recent prior sales reported.

The filing is a standard Form 144 disclosure indicating the holder plans to sell 1,500 shares with an aggregate market value of $339,816 on the NYSE through UBS Financial Services. The securities were acquired as RSUs in 2021 and 2023, which indicates sales stem from compensation vesting rather than open-market purchases. The absence of sales in the prior three months and the seller's attestation of no undisclosed material information are consistent with routine compliance and transparency expectations.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure; the transaction appears procedural and appropriately documented.

The filing documents required Rule 144 information: broker, share count, acquisition dates, and payment details. Listing the RSU origin and specific acquisition dates provides clarity on the holding period and transferability. The attestation about material information and the explicit broker details meet regulatory disclosure norms, supporting good governance on insider transactions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	1500	339816	48662715	08/26/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2021	RSU	Issuer			76	08/26/2025	NA
Common	02/17/2023	RSU	Issuer			1424	08/26/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Wesco International's (WCC) Form 144 report?

The Form 144 reports a proposed sale of 1,500 common shares through UBS with an aggregate market value of $339,816, approximate sale date 08/26/2025.

Where were the shares being sold acquired and when?

The shares were acquired as RSUs: 76 shares on 02/13/2021 and 1,424 shares on 02/17/2023.

Has the filer sold any WCC securities in the past three months?

No. The filing explicitly states Nothing to Report for securities sold in the past three months.

Which broker and exchange are involved in the planned sale?

The sale is to be executed through UBS Financial Services Inc and listed on the NYSE.

Does the filer attest to any undisclosed material information?

By signing, the filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.